Abbonarsi

Transcranial electrical stimulation (tES) in chronic pain patients: Effects on daily-reported symptoms - 21/12/25

Doi : 10.1016/j.accpm.2025.101613 
Antonio Gil-Ugidos a, , Jorge Alcántara-Espinosa b, Lara Rubal-Otero a, c, Mónica Mayo-Moldes d, Noelia Samartin-Veiga a, María Teresa Carrillo-de-la-Peña a
a Brain and Pain lab, Institute of Psychology (IPsiUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain 
b Group of Nursing Management and Care, Instituto De Investigación Sanitaria (IDIS), Santiago de Compostela, Spain 
c Foundation for Health Research Institute of Santiago de Compostela (FIDIS), Santiago de Compostela, Spain 
d Anesthesiology Department, University Hospital Álvaro Cunqueiro, Vigo, Spain 

Corresponding author.

Highlights

Transcranial electrical stimulation (tES) significantly reduced daily-reported pain intensity in chronic pain patients.
All clinical indices, except sleep quality, improved after tES (15 sessions).
Transcranial stimulation with direct (tDCS) or alternate current (tACS) produced similar results, superior to sham.
Inclusion of daily reports of outcome variables, assessed by time series analysis, can improve the design of clinical trials.
Home-based tES proved to be an effective, feasible procedure for the management of chronic pain.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Background

Transcranial electrical stimulation has yielded positive results for relieving pain in patients with chronic pain (CP), but the existing evidence is insufficient. In order to address some gaps in the literature, we conducted a randomized, double blind, sham-controlled clinical trial aimed at evaluating the feasibility and efficacy of home-based neurostimulation in a sample of 120 patients.

Methods

The patients completed 15 self-administered home-based sessions of either transcranial direct current stimulation (tDCS, n = 48), transcranial alternate current stimulation (tACS, n = 48), or sham stimulation (n = 24). The primary outcome variable, i.e., pain intensity, and related variables were assessed online (using numerical rating scales from 0 to 10) throughout 45 days (pre-treatment, treatment, and post-treatment periods each of 15 days).

Results

ANOVA (classical and Bayesian frameworks) and time series analysis consistently showed that both tDCS and tACS decreased the patients’ daily reported pain intensity (tDCS: tau = −0.553; p   <  0.001; tACS: tau = −0.563; p   <  0.001), pain unpleasantness (tDCS: tau = −0.489; p   <  0.001; tACS: tau = −0.537; p   <  0.001), interference due to pain (tDCS: tau = −0.368; p   <  0.001; tACS: tau = −0.424; p   <  0.001), and other symptoms such as fatigue (tDCS: tau = −0.255; p  = 0.02; tACS: tau = −0.556; p   <  0.001) and stress/anxiety (tDCS: tau = −0.245; p  = 0.02; tACS: tau = −0.685; p   <  0.001). No such improvement was observed in the group receiving the sham stimulation. The home-based treatment was associated with low drop-out rates (6.66%) and moderate satisfaction with the procedure (around 5 out of 10 in all groups), and minimal adverse effects of transcranial electrical stimulation were reported.

Conclusions

tDCS and tACS significantly reduced daily-reported pain in chronic pain patients. Home-based intervention could significantly reduce the high economic burden associated with chronic pain management in healthcare systems. Inclusion of daily reports assessed by time series analysis can improve clinical trials in the field of chronic pain.

Study registration

ClinicalTrials.gov ID number: NCT05099406 ( NCT05099406?term=NCT05099406%20%26rank=1 )

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Chronic pain, Transcranial electrical stimulation, Clinical trial, Home-based intervention, Time series analysis


Mappa


© 2025  The Author(s). Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 45 - N° 1

Articolo 101613- gennaio 2026 Ritorno al numero
Articolo precedente Articolo precedente
  • Amoxicillin-clavulanic acid resistance in the first postoperative pneumonia after cardiac surgery: Risk factors and outcomes from a 10-year cohort analysis
  • David Kovacs, Mohamed Rekik, Marie Lavollay, Fabrice Compain, Chahrazad Bey Boumezrag, Konstantinos Zannis, Christophe Caussin, Elodie Teil, Kamel Bouabdallah, Clarisse Blayau, Paul-Henri Wicky, Nicolas Allou, Marc Beaussier, Mathieu Desmard, Alexy Tran-Dinh, on behalf of the Heart Team IMM study group
| Articolo seguente Articolo seguente
  • Prevalence of perioperative functional disability using WHODAS 2.0 and associated adverse outcomes in surgical populations: A systematic review and meta-analysis
  • Priyanjli Sharma, Ellene Yan, Andy Cui, Rihana Kukkadi, Emily Au, Marina Englesakis, Frances Chung

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.